How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England by Audrey, Suzanne et al.
                          Audrey, S., Farr, M. C., Roderick, M. R., Evans, K., & Fisher, H.
(2020). How acceptable is adolescent self-consent for the HPV
vaccination: Findings from a qualitative study in south-west England.
Vaccine. https://doi.org/10.1016/j.vaccine.2020.09.074
Version created as part of publication process; publisher's layout; not normally made publicly
available
License (if available):
CC BY
Link to published version (if available):
10.1016/j.vaccine.2020.09.074
Link to publication record in Explore Bristol Research
PDF-document
This is the publisher's proof version of the article. It first appeared online via Elsevier at
https://www.sciencedirect.com/science/article/pii/S0264410X20312561. Please refer to any applicable terms of
use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/user-guides/explore-bristol-research/ebr-terms/
Vaccine xxx (xxxx) xxxContents lists available at ScienceDirect
Vaccine
journal homepage: www.elsevier .com/locate /vacc ineHow acceptable is adolescent self-consent for the HPV vaccination:
Findings from a qualitative study in south-west Englandhttps://doi.org/10.1016/j.vaccine.2020.09.074
0264-410X/ 2020 Published by Elsevier Ltd.
⇑ Corresponding author at: Bristol Medical School, Population Health Sciences,
Canynge Hall, 39 Whatley Road, Bristol BS8 2PR, UK.
E-mail address: suzanne.audrey@bristol.ac.uk (S. Audrey).
Please cite this article as: S. Audrey, M. Farr, M. Roderick et al., How acceptable is adolescent self-consent for the HPV vaccination: Findings from
itative study in south-west England, Vaccine, https://doi.org/10.1016/j.vaccine.2020.09.074Suzanne Audrey a,⇑, Michelle Farr a,b, Marion Roderick c, Karen Evans d, Harriet Fisher a
a Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
b The National Institute for Health Research Applied Research Collaboration West (NIHR ARC West) at University Hospitals Bristol NHS Foundation Trust, Bristol, UK
cDepartment of Paediatric Immunology & Infectious Diseases, Bristol Children’s Hospital, Bristol, UK
dHead of School Nursing (Sirona) and Specialist Nursing Services, Bristol and South Gloucestershire, UKa r t i c l e i n f o
Article history:
Received 16 March 2020
Received in revised form 17 September
2020
Accepted 25 September 2020
Available online xxxx
Keywords:
HPV
Vaccination
Consent
Qualitative research
Adolescent healtha b s t r a c t
Background: Human Papillomavirus (HPV) vaccination programmes have the potential to reduce the inci-
dence of cervical cancer. The preferred age for HPV vaccination is 12–13 years for optimal benefit. The
legal framework in England allows adolescents to be vaccinated without parental consent if they are
assessed as competent. A ‘South West Template Pathway on Self Consent for School Aged
Immunisations’ was developed to improve uptake of immunisations in south-west England.
Study aim: To examine how acceptable the new procedures are to the young women, parents and carers,
school staff and immunisation nurses involved.
Methods: The research was undertaken in two local authorities in south-west England during the
2017/18 and 2018/19 programme years. Semi-structured digitally recorded interviews were undertaken
with 53 participants: one health service manager, three immunisation nurses, five staff at alternative
education providers, three staff at mainstream schools, 19 young women and 22 parents. All recordings
were transcribed verbatim and thematic analysis was undertaken, assisted by NVivo software.
Results: Most participants were not fully aware of the legal framework that enables a young person to
self-consent to vaccination. There was a strong presumption that parents should make decisions affecting
the health of their children. The preferred age at which the HPV vaccination is administered (12–13 years)
contributed to reluctance in endorsing self-consent which was thought to have the potential to break
down trust between parents and school staff, and within families. In practice, formal self-consent was
rare.
Conclusion: Unresolved issues in relation to adolescent self-consent include public and professional per-
ceptions of young people’s rights and abilities to take responsibility for decisions affecting their health,
and concerns about the impact of self-consent on relationships both within families and between profes-
sionals and the families they serve.
 2020 Published by Elsevier Ltd.1. Introduction
Human Papillomavirus (HPV) vaccination programmes for ado-
lescent girls have the potential to reduce the incidence of cervical
cancer [1]. However, lower socio-economic status, some ethnic
groups, and being outside of ‘mainstream’ education are associated
with lower uptake of HPV vaccination which may exacerbate exist-
ing inequities in the incidence of, and mortality from, cervical can-
cer [2,3,4].For optimal benefit, the preferred age for HPV vaccination is
before sexual debut, and the schools-based vaccination pro-
gramme in England is predominantly administered in Year 8 when
students are aged 12–13 years. In England the legal framework
allows adolescents to be vaccinated without parental consent if
they are assessed as Gillick competent (believed to have enough
intelligence, competence and understanding to fully appreciate
what is involved in their medical treatment) [5] but written paren-
tal consent is usually sought [6]. Immunisation nurses and school
staff have shown reluctance to allow girls to self-consent to HPV
vaccination [7,8,9] and a qualitative systematic review and evi-
dence synthesis found, in a schools-based setting, the requirement
for written parental consent presented the greatest barrier to
accessing of the vaccine for some young women [10].a qual-
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the south-west of England with low uptake of HPV vaccination
[11]. In response, staff at PHE South West developed new consent
procedures which included student self-consent.
Before the new procedures were implemented, all female stu-
dents in Year 8 (aged 12–13 years) were provided with an informa-
tion leaflet about the HPV vaccination programme which they
were asked to take home and discuss with their parents, together
with a form asking parents or carers to provide written consent
or refusal for their daughter to receive the vaccine. Only young
women with a consent form signed by their parent, confirming
permission for the vaccine, were invited to the school-based vacci-
nation session.
Under the new procedures, information and consent forms were
distributed as usual but included new information for parents indi-
cating if a completed parental consent form was not returned the
immunisation team would assess their daughter and invite her to
self-consent if she could demonstrate understanding of the vacci-
nation, in line the Gillick competency framework [5]. Conse-
quently, young women without a signed parental consent form
also attended the school vaccination session.
During the vaccination session, young women with a consent
form signed by their parent received the vaccine. Those who
wanted to receive the vaccine but had not returned a parental con-
sent form spent more time with an immunisation nurse who
attempted to contact a parent by telephone to ask for verbal paren-
tal consent. If this was given, the young woman received the vac-
cine. If a parent or carer could not be contacted, the
immunisation nurse assessed the young woman’s competence,
her understanding of the purpose of the vaccine and possible side
effects, and any health issues that need to be taken into consider-
ation. If she was deemed competent and indicated she had dis-
cussed the vaccine with her parents and it would not cause
disagreement within the family if she was vaccinated, written con-
sent was obtained and she received the vaccine. Young women
who were not deemed competent, or indicated that vaccination
would cause disagreement at home, were not vaccinated but given
information about community-based clinics run by the immunisa-
tion nurses where the vaccine could be administered.
This paper focuses on qualitative research undertaken as part of
a larger study [12] and considers how acceptable the new proce-
dures were to young women, parents and carers, school staff and
immunisation nurses.2. Methods
The research was undertaken in two local authorities (LAs) in
south-west England where uptake rates of the HPV vaccination
programme were ranked 112th and 106th of 119 English LAs (ex-
cluding London). School recruitment took place during the
2017/18 and 2018/19 programme years. Mainstream schools in
which at least 12 female Year 8 students were not vaccinated dur-
ing the 2016/17 programme year were sent information about the
study and were invited to participate. Of the 15 schools identified,
four (26.7%) consented to take part. All alternative education pro-
vider settings (n = 17) were invited to participate in the study, of
which five (29.4%) consented.
During the 2017/18 programme year, only four young women
self-consented and all of them were given information about the
study and invited to participate in an interview. However, written
parental consent was required and this was not provided. Because
of the relatively low number of young women self-consenting, in
the 2018/19 programme year the inclusion criteria for young peo-
ple’s interviews were expanded to include all Year 8 young women
where a completed parental consent form for vaccination had not2been received by the school. In addition, as the number of young
women recruited in school settings was lower than anticipated,
community groups for parents and young people in Bristol and
South Gloucestershire were also approached (n = 18). Six commu-
nity groups agreed to assist recruitment.
Topic guides were developed to cover the same key issues (be-
liefs about the HPV vaccine, views and experiences of the HPV vac-
cination programme, and opinions about the new consent
procedures) with some adaptations relevant to the differing roles
of immunisation nurses, mainstream school staff, alternative edu-
cation providers, parents and young women. Digitally recorded
interviews took place in schools, community organisations, private
homes or by telephone, depending on the preferences of intervie-
wees. Interviews were one-to-one, or in pairs or small groups,
again to suit the participants.
All recordings were transcribed verbatim and thematic analysis
was undertaken assisted by QSR NVivo software [13]. We used
both an inductive and deductive approach to analyse the content,
focusing on our main research questions while identifying key
issues emerging from the data. Coding of all transcripts was under-
taken by one researcher (HF), while a second researcher (MF)
double-coded a sub-set of 12 transcripts to check for meaning, rel-
evance and reliability. A series of consensus meetings (SA, HF, MF)
were undertaken to review, refine and confirm the main themes
and codes relevant to the acceptability of the new consent proce-
dures. As the process of coding progressed and data were
extracted, key terms and phrases were retained while repetition
and extraneous text were removed (SA, HF, MF).
To illustrate key points, anonymised quotations have been cho-
sen. The following identifiers have been allocated: A (alternative
education provider), M (mainstream school), SS (school staff), CG
(community group), P (parent), YW (young woman), IN (immuni-
sation nurse), HM (health service manager); each followed by a
number.2.1. Funding and ethics
The study was funded by the National Institute for Health
Research Research for Patient Benefit (NIHR RfPB) programme
(project number PB-PG-0416-20013). The University of Bristol Fac-
ulty of Health Sciences Research Ethics Committee and the
National Health Service (NHS) Health Research Authority provided
the required approvals. All interviewees gave written informed
consent before participating in the study.3. Results
Four mainstream schools (including one serving an inner-city
ethnically diverse population, and another serving a predomi-
nantly White British low-income social housing estate) and five
alternative education providers were recruited to the qualitative
study. Semi-structured digitally recorded interviews were under-
taken with 53 participants: one health service manager and three
immunisation nurses who comprised the core immunisation team
(all female); five school staff (four female, one male) at alternative
education provision for young people with a range of physical and
sensory disabilities, or with differing educational and behavioural
needs; three staff at mainstream schools (two female, one male);
19 young women (eight Year 8 female students recruited through
participating schools, and 11 young women aged 12–17 years
attending community organisations), and; 22 parents (21 mothers
and one father recruited through community organisations provid-
ing support for parents and families). Of the 19 young women
interviewed: eight were from BAME communities; all of them
received the HPV vaccine; 12 returned a signed parental consent
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vaccine following parental verbal consent at the vaccination ses-
sion, and 1 self-consented.
Although the new consent procedures included adolescent self-
consent, it was rare in our study. Statistical analyses of the data
across the two LAs, undertaken for the larger study, show only
0.3 percent of young women self-consented during the 2-year
intervention period (Table 1). Parental verbal consent,
community-based clinics and general practice surgeries were more
likely routes to vaccination if written parental consent was not
provided for the school vaccination sessions.
The overarching themes presented below relate to understand-
ing the legal framework, primacy of parental consent, vaccination
beliefs, capacity to consent, prioritising relationships, and self-
consent in practice.
3.1. Understanding the legal framework
If a young person in England is assessed to be competent, they
have the right to accept or refuse health care including vaccina-
tions. However, in our sample, parents were unclear about the
legal framework and showed preference for delaying self-
consent: ‘‘I think they have to be 16 to give consent for sexual
activity so I think for injections and things like that, I still think
it should be 16” (CG01P04).
School staff also appeared unsure of the current legal frame-
work and legal implications of vaccinating without parental agree-
ment: ‘‘We all think it’s the parents but actually they [young
women] can give consent, is that correct?” (A04SS01); ‘‘My slight
concern would be the, what would be the legal protection for the
nurses doing the vaccines if they’d done that against the parents’
wishes” (A02SS01).
After the legal framework was explained during the interview,
some young women began to argue self-consent was acceptable:
‘‘I think they should just stick to legally what’s right. . . I think
there’s a lot more benefits that outweigh one angry parent email-
ing the school” (CG06YW02).
3.2. Primacy of parental consent
Almost all parents who were interviewed spoke about the
importance of being part of the decision-making process, and some
were particularly forthright: ‘‘As parents we make those decisions
for our children on what we feel is best” (CG01P09); ‘‘You wanna
stick a needle in my child without my permission, I’d knock you
out” (CG01P01).
Young women also acknowledged the role of parents as the
main consent providers: ‘‘It’s her parents whose, they’re in control
of her” (CG05YW02); ‘‘I think you should still respect the parent
because the parent is the one who has more knowledge in the sit-
uation” (M01YW02).
In contrast, some parents were less committed to the require-
ment for parental consent: ‘‘If they couldn’t get hold of me and
she was in there, and they told me afterwards ‘We decided we
didn’t have your consent, and we talked, and we felt she was com-
petent and we went ahead’, I would not have a problem with that”
(CG06P06); ‘‘I think the child should be allowed to have it doneTable 1
Route to vaccination for young women who received the HPV vaccine.
School setting
Parent written consent Parent verbal consent Adolescent self-
N (%) N (%) N (%)
5,538 (87.3) 299 (4.7) 17 (0.3)
3because I think it’s not the parents whose going be infected long
term, it’s going to be the child” (CG02P02).
Similar views were expressed by young women: ‘‘I don’t think
it’s fair if a child wants to have a vaccine for their future, so they
don’t get ill, and their parents say no” (CG06YW03); ‘‘It’s her body
so if she wants that, I think her parents should understand that if
she wants to take the consequences, if they believe there are any,
like it’s her decision” (CG06YW05).
School staff also articulated mixed views about the primacy of
parental consent: ‘‘I think it should be down to the parents. . . I
wouldn’t be happy for my children to be injected without my
knowledge” (M01SS01); ‘‘I think as long as it’s all upfront and clear
from the beginning then there’s absolutely no reason why a stu-
dent can’t, shouldn’t self-consent” (M02SS01). Parental consent
was perceived as particularly important in alternative educational
settings: ‘‘I wouldn’t dream of giving a vaccination without [paren-
tal] consent I’m afraid, here, in this sort of setting” (A02SS01).
The importance of parental decision-making was not only seen
in terms of young women receiving the vaccination against their
parents’ wishes. A frequently raised concern was whether, in real-
ising they could make the choice, young women would refuse the
vaccine: ‘‘There would be a tiny bit of me that would be worried if I
wasn’t in the loop that she just made some crazy decision with her
mates not to go ahead with it” (CG06P06); ‘‘I do think you’d have to
be careful they weren’t just not having it done because of the fear
of an injection” (CG02P02).
This perspective was confirmed by young women themselves:
‘‘I don’t think we’re allowed to make the decision completely by
ourselves, and I don’t think we should either because most kids
will go ‘Oh, it’s a needle, I’ll go out of it, I won’t do it’ but it’s actu-
ally quite important” (CG03YW01); ‘‘Who would want to have a
jab, because it would be painful, so I think it’s better for parents
to consent for their children” (CG05YW01).
While generally supporting the vaccination programme, school
staff acknowledged that young people had the right to refuse even
if their parents had signed a consent form: ‘‘I personally feel that
everyone should have it, but I think you can’t absolutely force it
on someone” (M02SS01).
3.3. Vaccination beliefs
Almost all interview participants were supportive of vaccina-
tions, including the HPV vaccine, to prevent ill health. Only one
parent spoke about her opposition to vaccination: ‘‘It was on the
internet because obviously I read up about everything. There’s
two doctors who’ve been sacked from their jobs ‘cos they said
the vaccine, the HPV, is actually giving girls cancer and stopping
them from having children” (CG01P01).
Professionals and parents discussed how autism had been
linked with the measles, mumps and rubella (MMR) vaccination.
But almost all participants, including parents of children with aut-
ism, discounted the link: ‘‘I mean he’s [adolescent son] got ADHD,
possible Asperger’s but as far as I’m concerned that wasn’t because
of vaccines he had” (CG01P09). It was, however, recognised that
other parents may have concerns: ‘‘I think there’s more fear in spe-
cial needs schools because there is still the anecdotal evidence that
vaccines, particularly the MMR, have caused the harm” (AO2SSO1).Community catch-up clinics General practice
consent
N (%) N (%)
217 (3.4) 219 (3.5)
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consent was appropriate where parents were opposed to vaccina-
tions: ‘‘The concern is where you’ve got families that maybe are
very anti and wouldn’t consent and that’s going to cause all kinds
of logistical problems” (CG02P04); ‘‘I would want my kids to be
vaccinated, I would think it would be a positive thing. But then
it’s not going to be so positive if it’s somebody that didn’t want
them to be vaccinated” (CG01P08); ‘‘I don’t agree with not having
vaccines but if she’s still a child I don’t think she should go against
her parents’ wishes” (CG05YW01).
But it was also suggested that young women should be able to
override their parents’ opinions: ‘‘I think being able to say ‘No,
actually I want a vaccine’, I think it’s really important because it
is their health and it is their body and it is them that it’s going to
affect” (CG03P01). One young woman described her own experi-
ence of being vaccinated despite her parents’ anti-vaccination
beliefs: ‘‘We got given like a big sheet and my mum didn’t want
me to get that [HPV vaccine] or the meningitis I think, so I signed
them myself and got it done anyway” (CG04YW01).
3.4. Capacity to consent
An important concern for parents was whether young women
eligible for the HPV vaccination were emotionally mature enough
to self-consent: ‘‘I wouldn’t trust [daughter] to make a decision
‘cos she can’t even go to the shop and get it right” (CG01P01);
‘‘We know what teenagers are like, they will just choose just
depending on how they feel in the moment” (CG01P07).
In schools for young people with additional educational needs,
staff were often keen to ensure parental consent: ‘‘I’d say here it
would be a capacity issue, are they are able to understand what
they’re consenting to, so we would want parents to consent”
(A01SS01). However, some staff wanted parity with mainstream
provision: ‘‘If children in mainstream are being told that they can
consent, then our children, the majority of them, would have that
capacity to consent. I think they should have every opportunity the
same as any child attending a mainstream school gets” (A03SS01);
‘‘If they’ve got the cognitive ability to understand what a vaccine
was, what’s actually going to happen to them, and the conse-
quences of it, then yeah” (A05SS01).
Although 16 years or older had been suggested as a suitable age
for self-consent to vaccination, some parents acknowledged that
decision-making skills were not simply related to age: ‘‘Some 13-
year olds can make really sensible decisions, and others you can’t
trust them to go to the shop” (CG02P04); ‘‘They might not be able
to communicate it verbally or as sophisticated as adults can do but
they have a feeling for themselves and they have their dignity and
they can say ‘Yes, that makes sense’ or ‘I like that’ or ‘No, I have a
feeling that’s not good for me’ and they can do that at every age”
(CG06P07).
The views of school staff varied in relation to the age at which
young women should be able to self-consent: ‘‘I still think that
it’s a little bit young, 13, to be self-consenting” (M01SS01); ‘‘Once
they get to Year 8 [aged 12–13 years] many of them, are in a good
position I would say to make an informed choice” (M02SS01). It
was suggested school staff should contribute to the process of
assessing competence: ‘‘I think that the school should have some
input as to whether they feel, with a professional judgement, that
a particular student is capable or in a position to be able to self-
consent” (M02SS01).
Young women also expressed differing opinions about whether
age was a good indicator of decision-making capacity: ‘‘I mean,
there are different mindsets and people have different intelligence
at the same age” (CG05YW01); ‘‘If people are well-informed like
via an assembly or something, I think at 12 you’re like, most people
are probably conscious enough to make that decision for them-4selves” (CG04YW01); ‘‘If you’re really young then I don’t think
you should be able to give consent, but if you’re like over the age
of like 13 maybe, then that would be quite a suitable age”
(M09YW01).
The immunisation team expressed difficulty in giving a
straightforward opinion about whether Year 8 is the right time
to encourage self-consent: ‘‘Year 8 is a hard one. Some of them
are still babies when they come and talk to you, they can’t even
say the word sex or pregnant without getting all embarrassed.
And some of them are really mature, really sensible, really know
their own mind and can give consent, so it’s a really tricky age. I
would love to say yes they should all be able to consent for their
own health matters and be able to consent for them but truly some
of them are not mature enough so it’s a real split at that age I think”
(IN002).
School staff and students also suggested the capacity of young
women to make informed decisions about vaccinations depended
on the quality of information provided: ‘‘Lots of students would
have said no because they probably need to look online to see what
it was, and there’s lots of lies, or it makes them scared”
(M09YW04); ‘‘It’s really important that students have been edu-
cated about what the vaccination is, why they’re having the vacci-
nation, something to do with the science behind it because
otherwise they’re not in a position I’d say to be able to make that
informed choice” (M02SS01).
3.5. Prioritising relationships
Relationships within families and between parents, school staff
and health professionals were often valued above the legal rights
of young women, and concerns were raised that the self-consent
process might ‘‘break down the trust between the school and the
parent. . . I would be really upset if I didn’t know about it and it
took place and I hadn’t been able to have a conversation, I’d be
angry” (CG02P02); ‘‘You need to still contact the parents because
. . . they could kick up a fuss” (CG02P06).
One school staff member suggested parents were more likely to
return a signed form, indicating refusal, if they were strongly
against vaccination: ‘‘As long as it’s all upfront and clear from the
beginning then there’s absolutely no reason why a student can’t,
shouldn’t self-consent. . . they [parents] would be more likely to
return the form if they didn’t want to have it done with a note say-
ing ‘Look, I don’t consent, OK’ as opposed to just not returning the
form at all” (M02SS01).
But the importance of protecting home-school relationships
was stressed by school staff in mainstream schools and alternative
education providers: ‘‘School, parent, child, so there’s a 3-way tri-
angle which everyone is involved - the self-consenting kind of cuts
the parent out of that triangle so then you’ve just got school, child”
(M10T01); ‘‘I suppose ultimately parental relationships are really
important to us. . . I would hate to drive a wedge in between us
and the family” (A04SS01).
Parents discussed potential negative impacts on relationships
within families if young women were encouraged to decide about
vaccination without parental consent: ‘‘The relationship between
child and parent is really important. . . you don’t want to have a rift
between the child and the parent open up” (CG01P07); ‘‘No child
should be in fear of something terrible happening at home for
any decision they make” (CG03P01). Consequently, although self-
consent might be considered a positive step for some, it might also
be an unfair burden: ‘‘The child should not be left alone with that
decision and with being torn apart, between the school says one
thing and the parent says another thing” (CG06P07).
The immunisation team raised similar concerns: ‘‘We want
them to have it, if they really want to have it done, but we don’t
want to be causing them harm within that family and breaking
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acknowledged potential problems at home if decisions were not
made in conjunction with parents: ‘‘It’s not right the kid should
be prevented from being able to make that choice because of the
parent, but at the same time, you do have to protect the kid and
make sure they won’t get into trouble for making that decision”
(CG04YW02); ‘‘You shouldn’t leave it so that the daughter has to
tell her parents that she’s got the vaccination without their con-
sent” (CG06YW05).
Although less common, some young women felt it was prefer-
able not to inform parents: ‘‘I don’t think the parents necessarily
even have to know. . . if a young person wants the vaccine enough,
they can perfectly well lie” (CG06YW02).
One young woman explained why she did not inform her par-
ents after signing the consent form herself: ‘‘I think they would
have just been slightly annoyed that I’d gone behind their backs
and done it because I think they’re pretty convinced in their idea
that it will give me autism. Probably it would have just annoyed
them” (CG04YW01). Another young woman suggested: ‘‘You have
to ask the young person first whether they want to involve, like the
parents to be involved. I think that’s probably more important than
parents being involved 100 percent of the time” (CG04YW01).3.6. Self-consent in practice
Seeking verbal consent by telephoning parents, as a stage before
resorting to self-consent, was generally thought to be a useful
addition to the consent process: ‘‘Initially when we talked about
self-consent there were lots of concerns. Certainly, as a team, that’s
why we suggested we do parental verbal consents as a step before
going to self-consent, so I think we’re quite happy with that”
(HM001); ‘‘As long as school always says at the beginning of the
phone call ‘Nothing to worry about’ because otherwise you think
your child has fallen down the stairs and broken both their legs
or something. Other than that, I can’t see any problem with that
at all” (CG06P02).
However, seeking telephone consent was not without criticism
as it may require a quick judgement by a parent who felt unpre-
pared: ‘‘If the parents, let’s say, have a religious problem and they
haven’t formed an opinion as yet and they feel emotional about the
topic and they don’t know where the position is and all of a sudden
you have a professional calling say ‘Yes or no please’. Now that cre-
ates quite a bit of pressure” (CG06P07).
Where parents could not be contacted, the preference for paren-
tal involvement still dominated the ‘self-consent’ process: ‘‘If the
child can’t tell us that mum or dad want me to have it done then
we don’t do self-consent” (IN002); ‘‘The parents have to have said
that they have seen the form, and they’ve had to have chatted to
the child about them wanting to have the immunisation, for me
to be happy to self-consent them” (IN001).
Concerns were raised about young women being responsible for
informing their parents that they had received the vaccination if
self-consent was progressed: ‘‘It’s just a bit unfair to put that on
a kid, I think. And they may never have discussed it so I don’t think,
they either wouldn’t know, or they’d just say the wrong thing and
then get into trouble at home or something which would be a bit
unfair” (CG01P03).
The immunisation team shared some of their experiences of
self-consenting young women: ‘‘We have had some people that
we’ve self-consented and the parents have come back and said
‘Thank you very much’, you know, ‘I haven’t been very organised
today, things have been a bit mad, I really did want her to have
it done so that’s great, thank you very much’” (HM001); ‘‘We have
had a couple I know that have called in most upset that we’d taken
self-consent” (IN002).5One notable example was described in which a young woman
said her parents wanted her to have the vaccine but she had forgot-
ten the parental consent form: ‘‘She was very aware of what the
vaccination was about. . . we felt she was able to give her consent
so we went ahead and gave the vaccination on the basis of self-
consent and then had a huge complaint from parents because actu-
ally they’d signed the form to say no but the girl hadn’t handed that
in. . . I think she was a very bright girl and knew how to get it with-
out her parents’ consent ‘cos she knew her parents would say no. . .
that girl won’t get her second dose next year ‘cos now we know the
parents have adamantly said no, she’s not to receive it. . . I think
that’s very sad” (IN003). In this situation the immunisation team
had followed the procedures and were supported by their
employer and Public Health England. No further action was taken
by the parents. While this example shows the young woman was
listened to and assessed, it also illustrates unresolved issues relat-
ing to adolescent self-consent.
As has already been noted, the right to self-consent includes the
right to refuse vaccination. The immunisation team spoke about
the process they would go through if a young woman, whose par-
ent had signed the consent form indicating they wanted her to
receive the vaccine, did not want to be vaccinated: ‘‘I would make
sure she had all the information and probably. . . once they’re one-
to-one with you, have all the information, calmed themselves
down, they will have it done, but again I’m not there to force. . .
ultimately the decision is hers and I would tell her that actually,
although it’s ideal to have it younger, that actually if she changes
her mind in two or three years’ time that she can contact her GP
practice and get it done there” (IN002).4. Discussion
4.1. Key findings
Most interview participants were not fully aware of the legal
framework enabling young people to self-consent to vaccination
if they are competent to do so. There was a strong presumption
that parental consent should be sought.
The preferred age at which the HPV vaccination is administered,
12 to 13 years, contributed to reluctance in endorsing self-consent.
The perceived variation in the maturity of Year 8 students made it
difficult for respondents to give an overall opinion about whether it
is the right time to encourage self-consent. This could be even
more pronounced for young women with complex developmental
and educational needs. The potential for new consent procedures
to highlight the right to refuse vaccination was also a concern.
Almost all interview participants held favourable beliefs about
vaccinations, but there was uncertainty about whether adolescent
self-consent was appropriate where parents were opposed to vac-
cinations. Concerns were expressed that self-consent procedures
could undermine trust between schools and parents. Furthermore,
although self-consent might be considered a positive step for
some, concerns were raised that it could put an unfair burden on
young people and may have a negative impact on family relation-
ships. In some cases, it was proposed that it might be preferable
not to inform parents if their adolescent daughter had received
the vaccination against their wishes.
To avoid some of the tensions associated with self-consent for
the HPV vaccination, the immunisation team included two steps
in the new procedures. Seeking verbal consent by telephoning par-
ents was predominantly welcomed. Where parents could not be
contacted, the assessment of competency included asking young
women the reasons for the parental consent form not being
returned and enabled the immunisation team to consider delaying
vaccination if there were concerns about disagreement within the
S. Audrey, M. Farr, M. Roderick et al. Vaccine xxx (xxxx) xxxfamily. This appeared to act as a barrier to self-consent, although it
was thought preferable to the possibility of young women being
placed in a difficult position at home or damaging trust between
parents and the school or health practitioners.
In practice, formal self-consent was rare. Where it occurred, it
was said to have worked well in some cases and less well in others.
The example that raised the most concern was of a young woman
who had deliberately gone against her parents’ wishes to receive
the vaccination. In contrast, another young woman explained that
she had avoided conflict with her parents by signing the form her-
self and simply not informing them.4.2. Strengths and limitations
The views and experiences of a change in consent procedures
are presented from the perspectives of a range of stakeholders.
However, recruitment of parents and young women for interview
proved difficult through the school system, and we were not able
to recruit sufficient Year 8 students and their parents, but we
increased the number of interviewees by recruiting through com-
munity organisations. Most of the interviewees were female, and
a male perspective is limited in our study. Almost all participants
held pro-vaccination beliefs and we are unable to provide direct
insights into how the new procedures are viewed by parents,
school staff or young women with strong anti-vaccination beliefs.
Self-consent was rare in our study and we can only provide limited
understanding of cases where self-consent took place. However,
we do share insights into the ways in which the new procedures
were implemented and adapted to fit more comfortably with the
prevailing view of parents’ rights to make decisions on behalf of
their adolescent children.4.3. Implications for research and practice
Our findings support a scoping review examining young peo-
ple’s healthcare which found that children and young people are
willing and able to make decisions about their healthcare services,
but the rhetoric of the choice agenda is not realized [14]. It has
been argued that strategies are needed to challenge prevailing
views of children requiring protection, so that it becomes more
acceptable for them to be involved in decisions about their health-
care [15]. Our research suggests self-consent was not a preferred
option for our sample of stakeholders. Some important issues
appear unresolved and require further exploration. What further
measures are required to support young people who wish to self-
consent? Should parents always be informed if their adolescent
child self-consents to vaccination and, if so, by whom and how?
Are there unmet information needs which, if addressed, could sup-
port understanding and acceptance of young people’s rights to self-
consent for vaccinations? From September 2019, the HPV vaccina-
tion programme has been extended to young men [16] but the
views of male stakeholders are underrepresented and there is
scope for more research in that area. In response to some of these
issues, co-production of information materials for young people is
being undertaken and examined in a new research study [17].5. Conclusion
This study has highlighted unresolved issues in relation to ado-
lescent self-consent for the HPV vaccination and potentially other
vaccines and healthcare initiatives for young people. These include
public and professional perceptions of young people’s rights and
abilities to take responsibility for decisions affecting their health,
and concerns about the impact of self-consent on relationships6within families and between professionals and the families they
serve.
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